Dąbrowska examined the expression of CXCL12 and CXCR4 in 100 breast cancer patients, revealing that analyzing the expression levels of CXCL12/CXCR4 can enhance the accuracy of breast cancer diagnosis (60). This evidence concerns the gene CXCR4 and breast carcinoma.